Table 4 Relevance of the extracted solutions
Report Section | Data Element | Fully Relevant Solutions, n (%)a | Partially Relevant Solutions, n (%)a | Fully Irrelevant Solutions, n (%)a |
|---|---|---|---|---|
Publication information | First author name | 63 (84.0) | 0 (0.0) | 12 (16.0) |
Date of publication | 64 (85.3) | 0 (0.0) | 11 (14.7) | |
Digital object identifier | 62 (82.7) | 0 (0.0) | 13 (17.3) | |
Meta information | Funding source | 16 (21.3) | 38 (50.7) | 21 (28.0) |
Funding number | 52 (69.3) | 13 (17.3) | 10 (13.3) | |
Registration number | 62 (82.7) | 5 (6.7) | 8 (10.7) | |
Enrollment | Eligibility criteria | 0 (0.0) | 66 (88.0) | 9 (12.0) |
Sample size | 31 (41.3) | 38 (50.7) | 6 (8.0) | |
Enrollment start date | 34 (45.3) | 15 (20.0) | 26 (34.7) | |
Enrollment end date | 37 (49.3) | 13 (17.3) | 25 (33.3) | |
Early stopping | 70 (93.3) | 3 (4.0) | 2 (2.7) | |
Intervention | Experimental arm(s) | 10 (13.3) | 56 (74.7) | 9 (12.0) |
Control arm(s) | 16 (21.3) | 49 (65.3) | 10 (13.3) | |
Route of administration | 53 (70.7) | 12 (16.0) | 10 (13.3) | |
Dose | 36 (48.0) | 22 (29.3) | 17 (22.7) | |
Frequency of administration | 39 (52.0) | 14 (18.7) | 22 (29.3) | |
Duration of treatment | 22 (29.3) | 25 (33.3) | 28 (37.3) | |
Outcome | Primary outcome(s) | 38 (50.7) | 24 (32.0) | 13 (17.3) |
Primary outcome time point | 7 (9.3) | 42 (56.0) | 26 (34.7) | |
Secondary outcome(s) | 23 (30.7) | 31 (41.3) | 21 (28.0) | |
Secondary outcome time point | 15 (20.0) | 27 (36.0) | 33 (44.0) | |
Summary measure | Median (IQR), n | 36 (16 to 53) | 22 (12 to 38) | 13 (10 to 22) |
Median (IQR), % | 48.0 (21.3 to 70.7) | 29.3 (16.0 to 50.7) | 17.3 (13.3 to 29.3) |